Anette Breindl

Neural stem cells open to alternate fates

Oct. 5, 2020

Researchers at the Karolinska Institute have spurred neural stem cells to produce myelin-forming oligodendrocytes, facilitating repair after spinal cord injury.

Microbiologists and meteorologists

Bacterial/viral combination is linked to postinfectious hydrocephalus

Oct. 2, 2020

By Anette Breindl

An international research team has identified a bacterial/viral combination more likely to be present in children with postinfectious hydrocephalus.

BioWorld MedTech’s Diagnostics Extra for Oct. 1, 2020

Oct. 1, 2020

By Meg Bryant and Anette Breindl

Keeping you up to date on recent developments in diagnostics, including: Brain imaging reveals signs of childhood trauma; Buyer beware for SARS-CoV-2 antibody detection; Tumor-associated cell cluster signal cancer alert.

Microbiologists and meteorologists

Bacterial/viral combination is linked to postinfectious hydrocephalus

Oct. 1, 2020

By Anette Breindl

An international research team has identified a bacterial/viral combination more likely to be present in children with postinfectious hydrocephalus.

Bench Press

Angiotensin inhibitors for AD prevention

Oct. 1, 2020

By Anette Breindl

BioWorld looks at translational medicine, including: Normal tissue gives clues to bladder cancer’s beginnings.

Bench Press

Microglia protect brain via inhibition

Sep. 30, 2020

By Anette Breindl

BioWorld looks at translational medicine, including: Vascular endothelial cells active co-conspirators in metastasis; Targeted delivery improves checkpoint blockade.

BioWorld MedTech’s Oncology Extra for Sept. 29, 2020

Sep. 29, 2020

By Mark McCarty and Anette Breindl

Keeping you up to date on recent developments in oncology, including: New nanoparticle could overcome aggregation-caused quenching for cancer treatment; Epigenetic resistance to PARP inhibitors; Statins help pancreatic tumors go from bad to worse; Sit up straight: PBT coming to a chair near you.

Bench Press

Carcinogens need not be mutagens

Sep. 29, 2020

By Anette Breindl

BioWorld looks at translational medicine, including: Myelin regulatory factor helps out pancreatic cancer cells.

BioWorld MedTech’s Neurology Extra for Sept. 25, 2020

Sep. 25, 2020

By Andrea Applegate and Anette Breindl

Keeping you up to date on recent developments in neurology, including: Putting virtual rehab for stroke patients to the test; Deep learning tool advances study of neural degeneration; Popular opinion correct on fear, anxiety.

Reduced diabetes risk is side effect of HIV, hep B drug class

Sep. 25, 2020

By Anette Breindl

Researchers at the University of Virginia have used a retrospective database analysis to show that the use of nucleoside reverse transcriptase inhibitors for the treatment of HIV or hepatitis B reduced the risk of developing type 2 diabetes by 33%.